These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Capula M; Perán M; Xu G; Donati V; Yee D; Gregori A; Assaraf YG; Giovannetti E; Deng D Drug Resist Updat; 2022 Sep; 64():100864. PubMed ID: 36115181 [TBL] [Abstract][Full Text] [Related]
83. Perspectives in the treatment of pancreatic adenocarcinoma. Cid-Arregui A; Juarez V World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356 [TBL] [Abstract][Full Text] [Related]
84. The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond. McAllister F; Khan MAW; Helmink B; Wargo JA Cancer Cell; 2019 Dec; 36(6):577-579. PubMed ID: 31951558 [TBL] [Abstract][Full Text] [Related]
85. Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition. Guardamagna M; Berciano-Guerrero MA; Villaescusa-González B; Perez-Ruiz E; Oliver J; Lavado-Valenzuela R; Rueda-Dominguez A; Barragán I; Queipo-Ortuño MI Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233289 [TBL] [Abstract][Full Text] [Related]
86. The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies? Brandi G; Turroni S; McAllister F; Frega G Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576078 [TBL] [Abstract][Full Text] [Related]
87. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics. Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918 [TBL] [Abstract][Full Text] [Related]
88. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Christenson ES; Jaffee E; Azad NS Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117 [TBL] [Abstract][Full Text] [Related]
89. [Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects]. Ye C; Zheng L; Yuan CH Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):10-15. PubMed ID: 30612387 [TBL] [Abstract][Full Text] [Related]
90. Targeting the gut and tumor microbiota in cancer. Park EM; Chelvanambi M; Bhutiani N; Kroemer G; Zitvogel L; Wargo JA Nat Med; 2022 Apr; 28(4):690-703. PubMed ID: 35440726 [TBL] [Abstract][Full Text] [Related]
91. Not just 'immunity': how the microbiota can reshape our approach to cancer immunotherapy. Boem F; Nannini G; Amedei A Immunotherapy; 2020 Apr; 12(6):407-416. PubMed ID: 32266849 [TBL] [Abstract][Full Text] [Related]
92. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Inamura K Semin Cancer Biol; 2021 May; 70():11-23. PubMed ID: 32580023 [TBL] [Abstract][Full Text] [Related]
93. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer. Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054 [No Abstract] [Full Text] [Related]
94. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy. Matson V; Chervin CS; Gajewski TF Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684 [TBL] [Abstract][Full Text] [Related]
95. Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations. Chen Z; Zhang S; Dong S; Xu H; Zhou W Front Immunol; 2022; 13():844401. PubMed ID: 35309293 [TBL] [Abstract][Full Text] [Related]
96. The critical role of tumor microbiome in cancer immunotherapy. Yang L; Wang Q; He L; Sun X Cancer Biol Ther; 2024 Dec; 25(1):2301801. PubMed ID: 38241173 [TBL] [Abstract][Full Text] [Related]
97. Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells. Yu Q; Newsome RC; Beveridge M; Hernandez MC; Gharaibeh RZ; Jobin C; Thomas RM Gut Microbes; 2022; 14(1):2112881. PubMed ID: 35980869 [TBL] [Abstract][Full Text] [Related]
98. B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy. Chen X; Li J; Chen Y; Que Z; Du J; Zhang J Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499340 [TBL] [Abstract][Full Text] [Related]
99. Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy. He Y; Huang J; Li Q; Xia W; Zhang C; Liu Z; Xiao J; Yi Z; Deng H; Xiao Z; Hu J; Li H; Zu X; Quan C; Chen J Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358736 [TBL] [Abstract][Full Text] [Related]
100. Intratumoral microbiota: new frontiers in tumor immunity. Zhang Z; Liao Y; Tang D Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]